Naranjan S. Dhalla / Arun Chockalingam / H. Ivan Berkowitz / Pawan K. Singal (Hgg.)
Frontiers in Cardiovascular Health
Herausgeber: Singal, Pawan K., Berkowitz, H. Ivan, Dhalla, Naranjan S., Chockalingam, Arun
Naranjan S. Dhalla / Arun Chockalingam / H. Ivan Berkowitz / Pawan K. Singal (Hgg.)
Frontiers in Cardiovascular Health
Herausgeber: Singal, Pawan K., Berkowitz, H. Ivan, Dhalla, Naranjan S., Chockalingam, Arun
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Understanding the pathophysiology; cellular mechanisms of disease progression; different risk factors for cardiovascular disease; dietary effects on cardiovascular health and cultural differences are as important as dealing with the economic burden of cardiovascular mortality and morbidity. Frontiers in Cardiovascular Health discusses the factors that lead to cardiovascular death and strategies for their prevention from molecule to population.
Andere Kunden interessierten sich auch für
- PérezEchocardiography and Cardiovascular Function: Tools for the Next Decade116,99 €
- Almudena Sánchez VillegasThe Prevention of Cardiovascular Disease Through the Mediterranean Diet69,99 €
- Lucio G. Costa / Clement E. Furlong (Hgg.)Paraoxonase (PON1) in Health and Disease77,99 €
- Pawan K. Singal / Ian M.C. Dixon / Lorrie A. Kirshenbaum / Naranjan S. Dhalla (Hgg.)Cardiac Remodeling and Failure231,99 €
- Akira Matsumori (ed.)Cardiomyopathies and Heart Failure216,99 €
- LaVailRetinal Degenerations154,99 €
- N.C. den Boer (Hrsg.)Clinical Chemistry118,99 €
-
-
-
Understanding the pathophysiology; cellular mechanisms of disease progression; different risk factors for cardiovascular disease; dietary effects on cardiovascular health and cultural differences are as important as dealing with the economic burden of cardiovascular mortality and morbidity. Frontiers in Cardiovascular Health discusses the factors that lead to cardiovascular death and strategies for their prevention from molecule to population.
Produktdetails
- Produktdetails
- Progress in Experimental Cardiology 9
- Verlag: Springer Netherlands
- 2003
- Seitenzahl: 616
- Erscheinungstermin: 30. September 2003
- Englisch
- Abmessung: 241mm x 160mm x 42mm
- Gewicht: 1188g
- ISBN-13: 9781402074516
- ISBN-10: 1402074514
- Artikelnr.: 21872666
- Progress in Experimental Cardiology 9
- Verlag: Springer Netherlands
- 2003
- Seitenzahl: 616
- Erscheinungstermin: 30. September 2003
- Englisch
- Abmessung: 241mm x 160mm x 42mm
- Gewicht: 1188g
- ISBN-13: 9781402074516
- ISBN-10: 1402074514
- Artikelnr.: 21872666
Dedication: A Tribute to Dr Bohuslav Ostdal. Preface. Acknowledgements.
I: Risk Factors and Cardiovascular Disease. 1. Inflammation and Cardiovascular Disease; J.T. Willerson. 2. The Role of Inflammation in Cardiac Function and Repair; M.L. Entman, et al. 3. Cardiac Repair Following Infarction; Yao Sun, K.T. Weber. 4. Protein and Phospholipids Composition of Human Myocardium in Children with Congenital Heart Disease; V. Pelouch, et al. 5. Human Atherosclerosis: New Participants? Yu.A. Romanov, et al. 6. Aging and Dietary Lipids Modulate Ca2+-Dependent Mitochondrial Function in the Post-Ischemic Heart; S. Pepe. 7. The Role of Nuclear Receptors in HDL Formation; G.A. Francis. 8. Vascular Complications in Diabetes: Risk Factors and Pathogenic Correlates; P.K. Chohan, et al. 9. Hypercholesterolemia and Cardiovascular Risk in Diabetic Patients; C. Bolego, et al. 10. Altered Substrate Utilization in the Diabetic Heart: Role of Lipoprotein Lipase; T. Chacko, et al. 11. Does Reperfusion Injury Cause Any Injury to the Myocardium? P. Ostadal, et al. 12. Fulminant Myocarditis From Lethal Disease to Survival; T. Izumi, et al. 13. Homosysteine/Coronary Atherosclerosis and Cardiac Transplantation: A Case Control Study; R.N. Kundur, et al. 14. Drug Development Based on Functional Genomics of Overloaded Cardiomyocytes: CPT1 vs. PPARalpha Effects of Etomoxir; H. Rupp, et al. 15. Mutational Profiles and Molecular Etiologies of Hypertrophic Cardiomyopathy and Dilated Cardiomyopathy in Asian Populations; A. Kimura, et al.
I: Risk Factors and Cardiovascular Disease. 1. Inflammation and Cardiovascular Disease; J.T. Willerson. 2. The Role of Inflammation in Cardiac Function and Repair; M.L. Entman, et al. 3. Cardiac Repair Following Infarction; Yao Sun, K.T. Weber. 4. Protein and Phospholipids Composition of Human Myocardium in Children with Congenital Heart Disease; V. Pelouch, et al. 5. Human Atherosclerosis: New Participants? Yu.A. Romanov, et al. 6. Aging and Dietary Lipids Modulate Ca2+-Dependent Mitochondrial Function in the Post-Ischemic Heart; S. Pepe. 7. The Role of Nuclear Receptors in HDL Formation; G.A. Francis. 8. Vascular Complications in Diabetes: Risk Factors and Pathogenic Correlates; P.K. Chohan, et al. 9. Hypercholesterolemia and Cardiovascular Risk in Diabetic Patients; C. Bolego, et al. 10. Altered Substrate Utilization in the Diabetic Heart: Role of Lipoprotein Lipase; T. Chacko, et al. 11. Does Reperfusion Injury Cause Any Injury to the Myocardium? P. Ostadal, et al. 12. Fulminant Myocarditis From Lethal Disease to Survival; T. Izumi, et al. 13. Homosysteine/Coronary Atherosclerosis and Cardiac Transplantation: A Case Control Study; R.N. Kundur, et al. 14. Drug Development Based on Functional Genomics of Overloaded Cardiomyocytes: CPT1 vs. PPARalpha Effects of Etomoxir; H. Rupp, et al. 15. Mutational Profiles and Molecular Etiologies of Hypertrophic Cardiomyopathy and Dilated Cardiomyopathy in Asian Populations; A. Kimura, et al.
Dedication: A Tribute to Dr Bohuslav Ostdal. Preface. Acknowledgements.
I: Risk Factors and Cardiovascular Disease. 1. Inflammation and Cardiovascular Disease; J.T. Willerson. 2. The Role of Inflammation in Cardiac Function and Repair; M.L. Entman, et al. 3. Cardiac Repair Following Infarction; Yao Sun, K.T. Weber. 4. Protein and Phospholipids Composition of Human Myocardium in Children with Congenital Heart Disease; V. Pelouch, et al. 5. Human Atherosclerosis: New Participants? Yu.A. Romanov, et al. 6. Aging and Dietary Lipids Modulate Ca2+-Dependent Mitochondrial Function in the Post-Ischemic Heart; S. Pepe. 7. The Role of Nuclear Receptors in HDL Formation; G.A. Francis. 8. Vascular Complications in Diabetes: Risk Factors and Pathogenic Correlates; P.K. Chohan, et al. 9. Hypercholesterolemia and Cardiovascular Risk in Diabetic Patients; C. Bolego, et al. 10. Altered Substrate Utilization in the Diabetic Heart: Role of Lipoprotein Lipase; T. Chacko, et al. 11. Does Reperfusion Injury Cause Any Injury to the Myocardium? P. Ostadal, et al. 12. Fulminant Myocarditis From Lethal Disease to Survival; T. Izumi, et al. 13. Homosysteine/Coronary Atherosclerosis and Cardiac Transplantation: A Case Control Study; R.N. Kundur, et al. 14. Drug Development Based on Functional Genomics of Overloaded Cardiomyocytes: CPT1 vs. PPARalpha Effects of Etomoxir; H. Rupp, et al. 15. Mutational Profiles and Molecular Etiologies of Hypertrophic Cardiomyopathy and Dilated Cardiomyopathy in Asian Populations; A. Kimura, et al.
I: Risk Factors and Cardiovascular Disease. 1. Inflammation and Cardiovascular Disease; J.T. Willerson. 2. The Role of Inflammation in Cardiac Function and Repair; M.L. Entman, et al. 3. Cardiac Repair Following Infarction; Yao Sun, K.T. Weber. 4. Protein and Phospholipids Composition of Human Myocardium in Children with Congenital Heart Disease; V. Pelouch, et al. 5. Human Atherosclerosis: New Participants? Yu.A. Romanov, et al. 6. Aging and Dietary Lipids Modulate Ca2+-Dependent Mitochondrial Function in the Post-Ischemic Heart; S. Pepe. 7. The Role of Nuclear Receptors in HDL Formation; G.A. Francis. 8. Vascular Complications in Diabetes: Risk Factors and Pathogenic Correlates; P.K. Chohan, et al. 9. Hypercholesterolemia and Cardiovascular Risk in Diabetic Patients; C. Bolego, et al. 10. Altered Substrate Utilization in the Diabetic Heart: Role of Lipoprotein Lipase; T. Chacko, et al. 11. Does Reperfusion Injury Cause Any Injury to the Myocardium? P. Ostadal, et al. 12. Fulminant Myocarditis From Lethal Disease to Survival; T. Izumi, et al. 13. Homosysteine/Coronary Atherosclerosis and Cardiac Transplantation: A Case Control Study; R.N. Kundur, et al. 14. Drug Development Based on Functional Genomics of Overloaded Cardiomyocytes: CPT1 vs. PPARalpha Effects of Etomoxir; H. Rupp, et al. 15. Mutational Profiles and Molecular Etiologies of Hypertrophic Cardiomyopathy and Dilated Cardiomyopathy in Asian Populations; A. Kimura, et al.